Moreover, it will provide the necessary foundation for understanding how PPAR agonists alter specific cell types and cell signaling in the human brain to provide novel therapeutic effects in the treatment of neurodegenerative diseases and addiction. Here, PPARA is linked to neurodegenerative disease.